Eli Lilly and Company (NYSE: LLY) has reached an extraordinary landmark by briefly crossing the $1 trillion market capitalization threshold this morning, before its share...
Eli Lilly
Eli Lilly (NYSE: LLY) has announced that data from a late-stage trial of its next-generation weight loss drug, retatrutide, is expected to be released later...
